Profile
ABEO VRTX REGN SGEN ARGX ALNY
Company Name Abeona Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $320.13M $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 0.14K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Dr. Vishwas Seshadri M.B.A., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
ABEO VRTX REGN SGEN ARGX ALNY
Quant Rating Score 1 2 4 3 3 1
Quant Rating Strong Sell Sell Buy Neutral Neutral Strong Sell
Trading
ABEO VRTX REGN SGEN ARGX ALNY
Last Close $5.49 $429.6 $547.67 $228.74 $569.12 $258.35
High 52 $6.86 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $4.06 $396.64 $546.39 $228.74 $356.01 $146.93
Price vs. 52 Week High -19.97 % -16.86 % -54.43 % 0 % -15.28 % -12.94 %
Price vs. 52 Week Low 35.22 % 8.31 % 0.23 % 0 % 59.86 % 75.83 %
Total Return
ABEO VRTX REGN SGEN ARGX ALNY
1 Month Return 25.63 % -10.93 % -4.95 % 0 % 0.94 % 6.21 %
3 Month Return -2.49 % -8.46 % -22.81 % 0 % -11.99 % -6.46 %
6 Month Return -14.22 % -16.86 % -33.89 % 0 % -4.51 % -6.88 %
9 Month Return 24.21 % -8.29 % -51.59 % 0 % 6.38 % -4.14 %
YTD Return -1.44 % 6.68 % -23.12 % 0 % -7.46 % 9.79 %
1 Year Return 23.37 % 2.53 % -43.42 % 0 % 48.77 % 70.67 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABEO VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -22.9 % -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ABEO VRTX REGN SGEN ARGX ALNY
Asset Growth 70.2 % -0.87 % -1.21 %
Gross Profit Growth -100 % 10.25 % 22.93 %
Revenue Growth -100 % 11.66 % 24.65 %
Revenue 3 Year -100 % 45.6 % 91.56 %
Revenue 5 Year - 163.93 % 215.48 %
Revenue 10 Year -100 % 1632.15 % 494.04 %
EBIT Growth -26.36 % -93.69 % 10.13 %
Net Income Growth -17.62 % -114.8 % 9.51 %
Net Income 3 Yeari Growth Per Share 93.1 % -122.89 % -763.59 %
Net Income 5 Yeari Growth Per Share 95.92 % -145.38 % -276.93 %
Net Income 10 Yeari Growth Per Share 97.62 % 33.84 % -624.16 %
Operating Income Growth -36.23 % -105.41 % 10.13 %
Operating Cash Flow Growth (CFG) -51.36 % -113.93 % 9.07 %
Operating 3 Year CFG 91.82 % -118.65 % -147.99 %
Operating 5 Year CFG 95.62 % -131.3 % -195.86 %
Operating 10 Year CFG 65.28 % 12.43 % -2622.09 %
EPS Growth 38.74 % -114.8 % 10.81 %
EPS Diluted Growth 38.74 % -114.97 % 10.81 %
Book Value Per Share 54.69 % -6.59 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -90.03 % 62.6 % 33.72 %
Share Holder 5 Year Equity Growth Per Share -98.79 % 168.85 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -90.87 % 1265.7 % 691.19 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share -100 % - -
Debt Growth 326.81 % 116.42 % -23.28 %
Free Cash Flow Growth -56.56 % -124.1 % 3.67 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2022
Profitability
ABEO VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM - 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -58.51 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -165.37 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM -69.53 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 100 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 99.26 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM - -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM -243.04 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM - 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 0.69 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM - 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM - 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM - 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM -1.36 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -1.42 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 238.06 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM - -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.37 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM -243.04 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -5.48 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM -4.81 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM -4.81 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
ABEO VRTX REGN SGEN ARGX ALNY
Revenue $0B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.06B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.06B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -1.55 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
ABEO VRTX REGN SGEN ARGX ALNY
Long Term Debt $0.02B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $0.06B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $0.04B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $0.07B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0.02B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $0.11B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
ABEO VRTX REGN SGEN ARGX ALNY
Net Income $-0.06B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.375
ABCL AbCellera Biologics Inc. 2.02
ABCM Abcam plc 23.99
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9802
ABPWW 0.02
ABSI Absci Corporation 2.74
ABUS Arbutus Biopharma Corporation 3.22
ABVC ABVC BioPharma, Inc. 1.21
ABVX Abivax SA American Depositary Shares 6.7
ACAD ACADIA Pharmaceuticals Inc. 17.44
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.608
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.34
ACIU AC Immune SA 1.68
ACLX Arcellx, Inc. 57.52
ACRV Acrivon Therapeutics, Inc. Common Stock 1.175
ETFs With Exposure to ABEO
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 277.95
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00036 123.37
VXF Vanguard Extended Market Index Fund 0 177.3
IWC iShares Micro-Cap ETF 0.0589 114.15
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 94.59
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 94.58
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.01
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47
VBINX Vanguard Balanced Index Fund Investor Shares 0 47
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
DFAT Dimensional U.S. Targeted Value ETF 0 51.19
DFAS Dimensional U.S. Small Cap ETF 0.00020616 60.2
DFAC Dimensional U.S. Core Equity 2 ETF 0 33.075
VTSAX Vanguard Total Stock Market Index Fund 0 135.4
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 134.56
VITSX Vanguard Total Stock Market Index Fund 0 135.42
IBRN iShares Neuroscience and Healthcare ETF 0.48271 21.56
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000165995 95.44
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 134.57
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
JKL iShares Morningstar Small-Cap Value ETF 0 172.726
SURI Simplify Propel Opportunities ETF 3.82779 13.8001
VEMPX Vanguard Extended Market Index InstlPlus 0 332.06
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 254.04
Unlock